Studies have shown that the gene expression level of VNN2 changed in monocytes from hyperlipidemia patients under atorvastatin treatment, which is a prescription medication used to improve cholesterol metabolism (Llaverias et al., 2008). The gene discussed is VNN2; the disease is hyperlipidemia.